Treatment-resistant Attention-deficit Hyperactivity Disorder: Clinical Significance, Concept, and Management

Mu-Hong Chen ； Kai-Lin Huang ； Ju-Wei Hsu ； Shih-Jen Tsai

《台灣精神醫學》 33卷2期 (2019/06) Pp. 66-75

https://doi.org/10.4103/TPSY.TPSY_14_19

摘要

Background: Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurodevelopmental disorder known to cause impairment across the lifespan. ADHD was ranked as approximately the 50th leading cause of global years lived with disability for children, coming in ahead of diabetes, meningitis, and intellectual disability. About 20%-40% of patients with ADHD would not achieve the treatment response and symptomatic remission, increasing future risks of substance abuse, suicidal behavior, and premature mortality. However, there is no standard consensus for defining treatment resistance in ADHD. Method: In this systematic review, we intend to focus on treatment-resistant ADHD in the aspects of disease definition, psychopathology, pathophysiology, and treatment. Results: We suggest that the more ideal strategy of defining treatment resistance should consider the improvement of ADHD symptoms and the global functioning simultaneously. Psychiatric comorbidities (i.e. destructive behavior disorders and mood disorders), physical comorbidities (i.e. epilepsy), and psychosocial adversities (i.e. parental psychopathology and poor family functioning) should be the first to be assessed in the evaluation of treatment response or resistance. The optimal medication adjustment or the combination of medications and psychotherapy may be the potential therapeutic strategy for treatment-resistant ADHD. Conclusion: Further studies would be necessary to elucidate the underlying mechanisms of treatment-resistant ADHD and to research the novel treatment strategies for ADHD.

關鍵字

physical comorbidities ； psychiatric comorbidities ； psychosocial adversities ； remission

參考文獻

Thapar A, Cooper M: Attention deficit hyperactivity disorder. Lancet2016; 387: 1240-50.

Faraone SV, Asherson P, Banaschewski T, et al.: Attention‑deficit/hyperactivity disorder. Nat Rev Dis Primers 2015; 1: 15020.

Vitola ES, Bau CH, Salum GA, et al.: Exploring DSM-5 ADHD criteria beyond young adulthood: phenomenology, psychometric properties and prevalence in a large three-decade birth cohort. Psychol Med 2017; 47: 744-54.

Biederman J, Faraone SV: Attention‑deficit hyperactivity disorder. Lancet 2005; 366: 237-48.

Asherson P, Buitelaar J, Faraone SV, et al.: Adult attention‑deficit hyperactivity disorder: key conceptual issues. Lancet Psychiatry 2016; 3: 568-78.